Expanding applications: The potential usage of 5-aminosalicylic acid in diverticular disease

Digestive Diseases and Sciences

Volumn 56, Issue 11, 2011, Pages 3112-3121

  Tursi, Antonio ^a   Joseph, Raymond E ^b,c   Streck, Paul ^b  

^a ASL BAT   (Italy)

^b SHIRE   (United States)

^c Ferring International   (United States)

Author keywords

5 Aminosalicylic acid; Diverticular disease; Inflammation; Mesalamine

Indexed keywords

ANTIBIOTIC AGENT; BALSALAZIDE; MESALAZINE; PROBIOTIC AGENT; RIFAXIMIN; SPASMOLYTIC AGENT; SULTAMICILLIN;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ANTIBIOTIC THERAPY; BIFIDOBACTERIUM; BLOATING; CLINICAL FEATURE; COLIC; COMORBIDITY; CONSTIPATION; DIARRHEA; DISEASE DURATION; DISEASE SEVERITY; DIVERTICULITIS; DIVERTICULOSIS; DRUG EFFICACY; ENTERITIS; ESCHERICHIA COLI; FEVER; GASTROINTESTINAL SYMPTOM; HIGH FIBER DIET; HUMAN; INFECTION COMPLICATION; LACTOBACILLUS CASEI; LEUKOCYTOSIS; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REMISSION; REVIEW; SACCHAROMYCES CEREVISIAE; TREATMENT DURATION; URINARY TRACT DISEASE; VOMITING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIVERTICULITIS; GASTROINTESTINAL AGENTS; HUMANS; MESALAMINE; PROBIOTICS; REMISSION INDUCTION; RIFAMYCINS;

EID: 82555192552     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-011-1731-x     Document Type: Review

References (80)

1. ST Bogardus Jr 2006 What do we know about diverticular disease? A brief overview J Clin Gastroenterol 40 S108 S111 16885691 10.1097/01.mcg.0000212603. 28595.5c (Pubitemid 44174902)
2. TG Parks 1975 Natural history of diverticular disease of the colon Clin Gastroenterol 4 53 69 1109820 1:STN:280:DyaE2M%2FnsVGrsg%3D%3D
3. G Comparato A Pilotto A Franze M Franceschi MF Di 2007 Diverticular disease in the elderly Dig Dis 25 151 159 17468551 10.1159/000099480 (Pubitemid 46663782)
4. National Digestive Diseases Information Clearinghouse (NDDIC). Digestive diseases in the United States: epidemiology and impact. 1994.
5. CW Konvolinka 1994 Acute diverticulitis under age forty Am J Surg 167 562 565 8209928 10.1016/0002-9610(94)90098-1 1:STN:280:DyaK2c3ntVCmsw%3D%3D (Pubitemid 24332512)
6. CD Cole AB Wolfson 2007 Case series: diverticulitis in the young J Emerg Med 33 363 366 17976749 10.1016/j.jemermed.2007.02.022 (Pubitemid 350181254)
7. PR Schauer R Ramos AA Ghiatas KR Sirinek 1992 Virulent diverticular disease in young obese men Am J Surg 164 443 446 1443367 10.1016/S0002-9610(05) 81177-8 1:STN:280:DyaK3s%2Fnt1KgtQ%3D%3D
8. W Aldoori M Ryan-Harshman 2002 Preventing diverticular disease. Review of recent evidence on high-fibre diets Can Fam Physician 48 1632 1637 12449547 (Pubitemid 35363587)
9. WH Aldoori EL Giovannucci EB Rimm AL Wing DV Trichopoulos WC Willett 1994 A prospective study of diet and the risk of symptomatic diverticular disease in men Am J Clin Nutr 60 757 764 7942584 1:STN:280:DyaK2M%2FivFSrsw%3D%3D (Pubitemid 24327875)
10. WH Aldoori EL Giovannucci HR Rockett L Sampson EB Rimm WC Willett 1998 A prospective study of dietary fiber types and symptomatic diverticular disease in men J Nutr 128 714 719 9521633 1:CAS:528:DyaK1cXit1Wqsrc%3D (Pubitemid 28158485)
11. MH Floch I Bina 2004 The natural history of diverticulitis: fact and theory J Clin Gastroenterol 38 S2 S7 15115921 10.1097/01.mcg.0000124003.07433.ee
12. F Hjern C Johansson A Mellgren NN Baxter A Hjern 2006 Diverticular disease and migration-the influence of acculturation to a Western lifestyle on diverticular disease Aliment Pharmacol Ther 23 797 805 16556182 10.1111/j.1365-2036.2006.02805.x 1:STN:280:DC%2BD287ms12lug%3D%3D (Pubitemid 43344599)
13. JR Korzenik 2006 Case closed? Diverticulitis: epidemiology and fiber J Clin Gastroenterol 40 S112 S116 16885692 10.1097/01.mcg.0000225503.59923.6c (Pubitemid 44174903)
14. MH Floch JA White 2006 Management of diverticular disease is changing World J Gastroenterol 12 3225 3228 16718843 (Pubitemid 43881347)
15. S Jun N Stollman 2002 Epidemiology of diverticular disease Best Pract Res Clin Gastroenterol 16 529 542 12406449 10.1053/bega.2002.0328
16. M Steel 2004 Colonic diverticular disease Aust Fam Physician 33 983 986 15630918
17. NH Stollman JB Raskin 1999 Diagnosis and management of diverticular disease of the colon in adults. Ad Hoc Practice Parameters Committee of the American College of Gastroenterology Am J Gastroenterol 94 3110 3121 10566700 10.1111/j.1572-0241.1999.01501.x 1:STN:280:DC%2BD3c%2FjtV2ktA%3D%3D
18. N Stollman JB Raskin 2004 Diverticular disease of the colon Lancet 363 631 639 14987890 10.1016/S0140-6736(04)15597-9 (Pubitemid 38264184)
19. A Ibele CP Heise 2007 Diverticular disease: update Curr Treat Options Gastroenterol 10 248 256 17547863 10.1007/s11938-007-0018-y (Pubitemid 46938934)
20. A Parra-Blanco 2006 Colonic diverticular disease: pathophysiology and clinical picture Digestion 73 47 57 16498252 10.1159/000089779
21. HN Aydin FH Remzi 2004 Diverticulitis: when and how to operate? Dig Liver Dis 36 435 445 15285520 10.1016/j.dld.2004.03.001 1:STN:280: DC%2BD2czot1Wluw%3D%3D (Pubitemid 41115444)
22. RS Boles Jr SM Jordan 1958 The clinical significance of diverticulosis Gastroenterology 35 579 582 13609810
23. J Rafferty P Shellito NH Hyman WD Buie 2006 Practice parameters for sigmoid diverticulitis Dis Colon Rectum 49 939 944 16741596 10.1007/s10350-006- 0578-2 (Pubitemid 44060847)
24. H Salzman D Lillie 2005 Diverticular disease: diagnosis and treatment Am Fam Physician 72 1229 1234 16225025 (Pubitemid 43104255)
25. U Haglund R Hellberg C Johnsen L Hulten 1979 Complicated diverticular disease of the sigmoid colon. An analysis of short and long term outcome in 392 patients Ann Chir Gynaecol 68 41 46 507737 1:STN:280:DyaL3c%2FmtlKhsg%3D%3D (Pubitemid 9213195)
26. S Janes A Meagher FA Frizelle 2005 Elective surgery after acute diverticulitis Br J Surg 92 133 142 15685694 10.1002/bjs.4873 1:STN:280:DC%2BD2M7hslyjug%3D%3D (Pubitemid 40269325)
27. S Ghorai TM Ulbright DK Rex 2003 Endoscopic findings of diverticular inflammation in colonoscopy patients without clinical acute diverticulitis: prevalence and endoscopic spectrum Am J Gastroenterol 98 802 806 12738459 10.1111/j.1572-0241.2003.07383.x (Pubitemid 36576305)
28. A Tursi G Brandimarte G Giorgetti W Elisei M Maiorano F Aiello 2008 The clinical picture of uncomplicated versus complicated diverticulitis of the colon Dig Dis Sci 53 2474 2479 18231855 10.1007/s10620-007-0161-2
29. A Tursi G Brandimarte W Elisei, et al. 2008 Assessment and grading of mucosal inflammation in colonic diverticular disease J Clin Gastroenterol 42 699 703 18347509 10.1097/MCG.0b013e3180653ca2
30. Wolff BG, Fleshman JW, Beck DE. Benign Colon: Diverticular Disease. The ASCRS Textbook of Colon and Rectal Surgery. New York: Springer; 2010:269.
31. F Di Mario G Comparato L Fanigliulo, et al. 2006 Use of mesalazine in diverticular disease J Clin Gastroenterol 40 S155 S159 16885700 10.1097/01.mcg.0000225509.98041.4b 1:CAS:528:DC%2BD28XnslGlurY%3D (Pubitemid 44174911)
32. L Dubuquoy C Rousseaux X Thuru, et al. 2006 PPARgamma as a new therapeutic target in inflammatory bowel diseases Gut 55 1341 1349 16905700 10.1136/gut.2006.093484 1:CAS:528:DC%2BD28XhtVehurfL (Pubitemid 44277368)
33. Lewis JD, Lichtenstein GR, Deren JJ, et al. A randomized, placebo-controlled trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis. Gastroenterology. 2007;13:Abstract 639a.
34. G Rogler T Andus 1998 Cytokines in inflammatory bowel disease World J Surg 22 382 389 9523521 10.1007/s002689900401 1:STN:280:DyaK1c7osVWhsA%3D%3D (Pubitemid 28113526)
35. C Favier C Neut C Mizon A Cortot JF Colombel J Mizon 1997 Fecal beta-D-galactosidase production and Bifidobacteria are decreased in Crohn's disease Dig Dis Sci 42 817 822 9125655 10.1023/A:1018876400528 1:STN:280:DyaK2s3ntVGksA%3D%3D (Pubitemid 27196036)
36. L Ludeman BF Warren NA Shepherd 2002 The pathology of diverticular disease Best Pract Res Clin Gastroenterol 16 543 562 12406450 10.1053/bega.2002.0297
37. C Manichanh L Rigottier-Gois E Bonnaud, et al. 2006 Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach Gut 55 205 211 16188921 10.1136/gut.2005.073817 1:CAS:528:DC%2BD28XhsFaqsL8%3D (Pubitemid 43117279)
38. MA Peppercorn 2004 The overlap of inflammatory bowel disease and diverticular disease J Clin Gastroenterol 38 S8 S10 15115922 10.1097/01.mcg.0000123993.13937.ec
39. MH Floch 2006 A hypothesis is diverticulitis a type of inflammatory bowel disease? J Clin Gastroenterol 40 S121 S125 16885694 10.1097/01.mcg.0000225502. 29498.ba (Pubitemid 44174905)
40. GE Sladen MI Filipe 1984 Is segmental colitis a complication of diverticular disease? Dis Colon Rectum 27 513 514 6147239 10.1007/BF02555508 1:STN:280:DyaL2c3osVynsA%3D%3D (Pubitemid 14060273)
41. A Tursi 2007 New physiopathological and therapeutic approaches to diverticular disease of the colon Expert Opin Pharmacother 8 299 307 17266465 10.1517/14656566.8.3.299 1:CAS:528:DC%2BD2sXhtFGltbc%3D
42. SE Janes A Meagher FA Frizelle 2006 Management of diverticulitis BMJ 332 271 275 16455722 10.1136/bmj.332.7536.271 (Pubitemid 43235335)
43. RS Sandler JE Everhart M Donowitz, et al. 2002 The burden of selected digestive diseases in the United States Gastroenterology 122 1500 1511 11984534 10.1053/gast.2002.32978 (Pubitemid 34465190)
44. NJ Shaheen RA Hansen DR Morgan, et al. 2006 The burden of gastrointestinal and liver diseases, 2006 Am J Gastroenterol 101 2128 2138 16848807 10.1111/j.1572-0241.2006.00723.x (Pubitemid 44337640)
45. World Gastroenterology Organisation (WGO). Practice guidelines 2007: diverticular disease. Available at http://www.worldgastroenterology.org/assets/ downloads/en/pdf/guidelines/07-diverticular-disease.pdf.2007 ; Accessed 10.02.2010.
46. G Peppas IA Bliziotis D Oikonomaki ME Falagas 2007 Outcomes after medical and surgical treatment of diverticulitis: a systematic review of the available evidence J Gastroenterol Hepatol 22 1360 1368 17716342 10.1111/j.1440-1746.2007. 05118.x (Pubitemid 47274598)
47. F Hjern T Josephson D Altman, et al. 2007 Conservative treatment of acute colonic diverticulitis: are antibiotics always mandatory? Scand J Gastroenterol 42 41 47 17190761 10.1080/00365520600780650 (Pubitemid 46039638)
48. C Rousseaux B Lefebvre L Dubuquoy, et al. 2005 Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma J Exp Med 201 1205 1215 15824083 10.1084/jem.20041948 1:CAS:528:DC%2BD2MXjs1CitLg%3D (Pubitemid 40629065)
49. WF Stenson E Lobos 1982 Sulfasalazine inhibits the synthesis of chemotactic lipids by neutrophils J Clin Invest 69 494 497 6120182 10.1172/JCI110474 1:CAS:528:DyaL38XitFSntLg%3D (Pubitemid 12177629)
50. YR Mahida CE Lamming A Gallagher AB Hawthorne CJ Hawkey 1991 5-Aminosalicylic acid is a potent inhibitor of interleukin 1 beta production in organ culture of colonic biopsy specimens from patients with inflammatory bowel disease Gut 32 50 54 1846838 10.1136/gut.32.1.50 1:STN:280:DyaK3M7it1KktA%3D%3D
51. D Rachmilewitz F Karmeli LW Schwartz PL Simon 1992 Effect of aminophenols (5-ASA and 4-ASA) on colonic interleukin-1 generation Gut 33 929 932 1353743 10.1136/gut.33.7.929 1:CAS:528:DyaK38Xmt1KjtLs%3D
52. GC Kaiser F Yan DB Polk 1999 Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor kappaB activation in mouse colonocytes Gastroenterology 116 602 609 10029619 10.1016/S0016-5085(99)70182-4 1:CAS:528:DyaK1MXhvVOnt7k%3D (Pubitemid 29106768)
53. LJ Egan DC Mays CJ Huntoon, et al. 1999 Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity J Biol Chem 274 26448 26453 10473604 10.1074/jbc.274.37.26448 1:CAS:528:DyaK1MXmtVKlsrY%3D (Pubitemid 29437098)
54. I Ahnfelt-Ronne OH Nielsen A Christensen E Langholz V Binder P Riis 1990 Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid Gastroenterology 98 1162 1169 1969825 1:STN:280:DyaK3c3hsFSqsQ%3D%3D (Pubitemid 20143098)
55. E Trepsi C Colla P Panizza, et al. 1999 Therapeutic and prophylactic role of mesalazine (5-ASA) in symptomatic diverticular disease of the large intestine. 4 year follow-up results Minerva Gastroenterol Dietol 45 245 252 16498335 1:STN:280:DC%2BD287htFeltQ%3D%3D (Pubitemid 30084200)
56. G Brandimarte A Tursi 2004 Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease Med Sci Monit 10 I70 I73
57. F Di Mario G Aragona G Leandro, et al. 2005 Efficacy of mesalazine in the treatment of symptomatic diverticular disease Dig Dis Sci 50 581 586 15810646 10.1007/s10620-005-2478-z 1:CAS:528:DC%2BD2MXisFKhtr4%3D (Pubitemid 40543752)
58. G Comparato L Fanigliulo LG Cavallaro, et al. 2007 Prevention of complications and symptomatic recurrences in diverticular disease with mesalazine: a 12-month follow-up Dig Dis Sci 52 2934 2941 17410435 10.1007/s10620-007-9766-8 1:CAS:528:DC%2BD2sXhtFSlsrjJ (Pubitemid 47512549)
59. G Comparato L Fanigliulo G Aragona, et al. 2007 Quality of life in uncomplicated symptomatic diverticular disease: is it another good reason for treatment? Dig Dis 25 252 259 17827951 10.1159/000103896 (Pubitemid 350194179)
60. A Tursi G Brandimarte GM Giorgetti W Elisei 2007 Continuous versus cyclic mesalazine therapy for patients affected by recurrent symptomatic uncomplicated diverticular disease of the colon Dig Dis Sci 52 671 674 17253134 10.1007/s10620-006-9551-0 1:CAS:528:DC%2BD2sXhslWjuro%3D
61. Kruis W, Meier E, Schumacher M, et al. Treatment of painful diverticular disease of the colon with mesalamine: a placebo-controlled study. Gastroenterology. 2007;132:A-191-Abstract S1187.
62. SV Kane 2006 Systematic review: adherence issues in the treatment of ulcerative colitis Aliment Pharmacol Ther 23 577 585 16480396 10.1111/j.1365-2036.2006.02809.x 1:CAS:528:DC%2BD28XjslWgur8%3D
63. MJ Shale SA Riley 2003 Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease Aliment Pharmacol Ther 18 191 198 12869079 10.1046/j.1365-2036.2003.01648.x 1:CAS:528: DC%2BD3sXntFGmtL8%3D (Pubitemid 36951655)
64. Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis (NCT00695643). Available at: http://www.clinicaltrials.gov/ct2/ show/NCT00695643 ; Accessed 2.02.2010.
65. Prevention of Recurrence of Diverticulitis (PREVENT 1) (NCT00545740). Available at http://www.clinicaltrials.gov/ct2/show/NCT00545740 ; Accessed 2.02.2010.
66. Prevention of Recurrence of Diverticulitis (PREVENT 2) (NCT00545103). Available at http://www.clinicaltrials.gov/ct2/show/NCT00545103 ; Accessed 2.02.2010.
67. A Tursi G Brandimarte R Daffina 2002 Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon Dig Liver Dis 34 510 515 12236485 10.1016/S1590-8658(02)80110-4 1:CAS:528:DC%2BD38XmvFOqu7c%3D (Pubitemid 34830693)
68. MM Gronlund H Arvilommi P Kero OP Lehtonen E Isolauri 2000 Importance of intestinal colonisation in the maturation of humoral immunity in early infancy: a prospective follow up study of healthy infants aged 0-6 months Arch Dis Child Fetal Neonatal Ed 83 F186 F192 11040166 10.1136/fn.83.3.F186 1:STN:280:DC%2BD3M%2FksVOluw%3D%3D
69. PV Kirjavainen E Apostolou T Arvola SJ Salminen GR Gibson E Isolauri 2001 Characterizing the composition of intestinal microflora as a prospective treatment target in infant allergic disease FEMS Immunol Med Microbiol 32 1 7 11750215 10.1111/j.1574-695X.2001.tb00526.x 1:CAS:528:DC%2BD3MXpt1amtro%3D (Pubitemid 34025068)
70. PG Falk LV Hooper T Midtvedt JI Gordon 1998 Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology Microbiol Mol Biol Rev 62 1157 1170 9841668 1:STN:280:DyaK1M%2FlvVWgsQ%3D%3D (Pubitemid 28558295)
71. A Tursi G Brandimarte GM Giorgetti W Elisei 2005 Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon World J Gastroenterol 11 2773 2776 15884120 (Pubitemid 40704246)
72. F Guarner GJ Schaafsma 1998 Probiotics Int J Food Microbiol 39 237 238 9553803 10.1016/S0168-1605(97)00136-0 1:STN:280:DyaK1c3hsVChsw%3D%3D (Pubitemid 28132640)
73. L Petruzziello F Iacopini M Bulajic S Shah G Costamagna 2006 Review article: uncomplicated diverticular disease of the colon Aliment Pharmacol Ther 23 1379 1391 16669953 10.1111/j.1365-2036.2006.02896.x 1:STN:280: DC%2BD283pt1Whuw%3D%3D
74. P Gionchetti C Amadini F Rizzello, et al. 2002 Probiotics-role in inflammatory bowel disease Dig Liver Dis 34 S58 S62 12408442 10.1016/S1590-8658(02)80166-9
75. EM Quigley 2007 Probiotics in the management of colonic disorders Curr Gastroenterol Rep 9 434 440 17991347 10.1007/s11894-007-0055-7
76. ME Sanders 1999 Probiotics Food Technol 53 66 77
77. P Fric M Zavoral 2003 The effect of non-pathogenic Escherichia coli in symptomatic uncomplicated diverticular disease of the colon Eur J Gastroenterol Hepatol 15 313 315 12610327 10.1097/00042737-200303000-00015 (Pubitemid 36337852)
78. A Tursi G Brandimarte GM Giorgetti W Elisei 2006 Mesalazine and/or Lactobacillus casei in preventing recurrence of symptomatic uncomplicated diverticular disease of the colon: a prospective, randomized, open-label study J Clin Gastroenterol 40 312 316 16633103 10.1097/01.mcg.0000210092.77296.6d (Pubitemid 44309523)
79. A Tursi G Brandimarte GM Giorgetti W Elisei 2008 Mesalazine and/or Lactobacillus casei in maintaining long-term remission of symptomatic uncomplicated diverticular disease of the colon Hepatogastroenterology 55 916 920 18705297 (Pubitemid 351975955)
80. A Tursi G Brandimarte GM Giorgetti W Elisei F Aiello 2007 Balsalazide and/or high-potency probiotic mixture (VSL#3) in maintaining remission after attack of acute, uncomplicated diverticulitis of the colon Int J Colorectal Dis 22 1103 1108 17390144 10.1007/s00384-007-0299-6 (Pubitemid 47500254)